Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.
about
Light chain (AL) amyloidosis: update on diagnosis and managementImmunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatmentUpdate on treatment of light chain amyloidosisRadioimmunodetection of amyloid deposits in patients with AL amyloidosis.Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failureLong-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis.Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.Amyloidosis: pathogenesis and new therapeutic options.Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract.Macroglossia due to Systemic Amyloidosis: Is There a Role for Radiotherapy?Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsHigh-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement.Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial.Bronchoscopic Diagnosis and Treatment of Primary Tracheobronchial Amyloidosis: A Retrospective Analysis from ChinaDiagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion.Al amyloidosisTransthyretin (TTR) cardiac amyloidosis.Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trialPerspectives in treatment of AL amyloidosis.Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosisLenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement.Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease.Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115.The burden of amyloid light chain amyloidosis on health-related quality of life.Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis.Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.Light chain amyloidosis 2012: a new era.Recent advances in the diagnosis and management of cardiac amyloidosis.Immunoglobulin light chain amyloidosis.Cardiac amyloidosis: where are we today?Emerging Advances in the Management of Cardiac Amyloidosis.New and developing therapies for AL amyloidosis.Newer Therapies for Amyloid Cardiomyopathy.Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis.Hepatomegaly, weight loss and general malaise - the first manifestations of primary systemic amyloidosis.
P2860
Q21198863-D36EA751-CCE4-423C-9464-F8479FEB3AE9Q26827340-CBC7C493-8D88-428F-8ADA-57ABE3BC9880Q26829735-EB2B7B65-AD47-4514-AC1E-5E6C19A3E2C1Q34193315-71620878-26C9-4F4B-9407-522E160C222AQ34240595-A03E5AF8-8C02-4811-8ABD-11545485E4DFQ34353682-2481DECF-7A3E-423D-8D74-A318A21AF8C0Q34448455-E5DD8DD6-82C4-4E1D-858A-6CDAC92A79FCQ34450910-397B99F0-61A2-4335-9D48-040EF7F37058Q35111771-3A46BBD5-27AE-4A07-AE06-142F326804BAQ35208216-9AC3FF3C-A90B-442B-9486-0BB289818995Q35225655-EB80872F-B3EB-48F1-BC5F-DD7709596431Q35485742-C5920370-0216-4FEB-B9A0-0A19E4B67F37Q35750326-FFA1F6BE-B107-4C46-93A9-3B1F350DE07DQ36163205-23B1B043-525F-47ED-9EE4-022B71A3E04AQ36280607-252D2F73-A26A-46B5-8175-5CE1F9E93ED5Q36301287-23C0E02E-AE13-47EF-B77D-F8A42106F8DEQ36392233-CB65C5B5-E711-4CB1-815C-586619296C3AQ36408438-C9C90854-B430-46C3-B321-3270A4AB75A0Q36805878-C12029E1-FE66-4C44-B23F-E4929FA0BC99Q37045885-ED55E6C2-F925-42BC-A19C-669A94BDB5A6Q37172003-0F06C831-4FA2-4728-BC78-CC4BD64F8068Q37212712-17450C15-0CFF-4871-850D-897E11AD5C15Q37246780-C0B398D6-42D3-4302-98A5-300F07F30CDDQ37373292-E6DC27BD-9CAE-40A2-9013-3F88517BB1D8Q37593524-D33EAE08-5E53-4519-B6A0-D0E95A593DBDQ37832199-F029CE42-276E-48B6-8F59-61721C595B80Q37904673-4FB1F022-A50E-4CD7-BF93-CC2E6FA458F6Q37995198-1400A5EF-A5F7-46D2-8B4D-1B93374A1DFDQ37999957-BFB7DB7A-E773-499D-AA57-1559E1750992Q38070916-EA35B21C-9D36-45EB-9310-6C688C7E0229Q38072108-BDBCEE83-B42C-4DA5-A2FB-A6BA34A23337Q38171831-649A3385-1315-4873-A566-673DFDF5FB78Q38172295-D99032CB-813D-46D6-B45D-6003EDB99A47Q38528406-BEE5496A-C38B-41A2-8A57-2B5F3BC41BAEQ38587648-B796CCC0-4B37-4B9E-BB72-5679BFE1390CQ38779623-3C1E54AD-4541-4C1C-9911-2EDFC913999EQ38920614-EF9DFB02-1977-4703-A751-46A87853EEE3Q38928383-E510EF06-E2FC-42C5-967D-74F2E232A93EQ39103973-E9167061-B9E9-4310-8E4B-C6C98AB0E645Q39788754-1CFE61A5-A1C4-4DD6-A86A-DCF4E46CC899
P2860
Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Long-term outcome of patients ...... and stem-cell transplantation.
@ast
Long-term outcome of patients ...... and stem-cell transplantation.
@en
type
label
Long-term outcome of patients ...... and stem-cell transplantation.
@ast
Long-term outcome of patients ...... and stem-cell transplantation.
@en
prefLabel
Long-term outcome of patients ...... and stem-cell transplantation.
@ast
Long-term outcome of patients ...... and stem-cell transplantation.
@en
P2093
P2860
P1433
P1476
Long-term outcome of patients ...... and stem-cell transplantation.
@en
P2093
David C Seldin
Gheorghe Doros
Kathleen T Finn
Martha Skinner
P2860
P304
P356
10.1182/BLOOD-2007-07-099481
P407
P577
2007-08-02T00:00:00Z